Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is a 100% increase over the number of companies cited in the previous year.
The citations in the county include:
- You did not conduct operations under conditions and controls necessary to minimize the potential for allergen cross-contact.
- The quality control unit lacks the responsibility and authority to approve and reject all drug products.
- Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Lagusta's Luscious, LLC | Food and Cosmetics | 12/14/2023 | Manufacturing, processing, packing, holding - Controls |
Ultra Seal Corporation | Drugs | 09/20/2023 | Approve or reject components, products |
Ultra Seal Corporation | Drugs | 09/20/2023 | Equipment Design, Size and Location |
Ultra Seal Corporation | Drugs | 09/20/2023 | Written procedures not established/followed |
Ultra Seal Corporation | Drugs | 09/20/2023 | Control procedures to monitor and validate performance |
Ultra Seal Corporation | Drugs | 09/20/2023 | Storage under appropriate conditions |